Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
LAFAYETTE, LA / ACCESS Newswire / September 24, 2026 / (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that Michael Moore, President of Viemed, has adopted an automatic securities disposition plan (the "ASDP") relating to common shares of the Company.Under applicable securities laws, insiders are subject to limits on their ability to sell shares.
Viemed Healthcare’s updated analyst model now places fair value at $12.50, compared with the previous $11.00 estimate, which signals a reset in how the stock is being framed. Supportive analysts link this change to Viemed Healthcare’s position in home respiratory care and its exposure to a broader mix of equipment, while more cautious voices point to near term profitability pressures and a tighter margin of safety. As you read on, you will see how these shifting views shape the evolving...
Viemed Healthcare Inc (VMD) posts 24% revenue growth to $78.1 million, raises full-year guidance, but faces adjusted EBITDA margin compression from business diversification.
Moby summary of Viemed Healthcare, Inc.'s Q2 2026 earnings call
LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it ...
LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it ...
The United States market has shown robust performance recently, climbing 1.8% in the last week and up 28% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this thriving environment, identifying stocks that combine strong fundamentals with growth potential can uncover hidden opportunities for investors seeking to capitalize on these positive trends.
The United States market has shown robust performance recently, climbing 2.5% in the last 7 days and achieving a 26% increase over the past year, with earnings projected to grow by 17% annually. In this favorable environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD). Viemed's 1Q26 results showed improving growth quality, not just reported scale. Sleep, resupply, and maternal health are becoming larger contributors, reducing reliance on legacy ventilation and improving capital efficiency. At the same time, ventilation appears to be moving through the NCD transition, with...
Moby summary of Viemed Healthcare, Inc.'s Q1 2026 earnings call
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.